Generics

Filter

Current filters:

None

Popular Filters

60 to 84 of 1198 results

Teva’s 2nd-qtr sales and earnings miss analysts' estimates

Teva’s 2nd-qtr sales and earnings miss analysts' estimates

31-07-2014

Israel’s Teva Pharmaceutical Industries, the world’s biggest generics drugmaker, reported disappointing…

CopaxoneFinancialGenericsIsraelTeva Pharmaceutical Industries

Ranbaxy down on same quarter last year following FDA fine

Ranbaxy down on same quarter last year following FDA fine

30-07-2014

Indian generic pharma company Ranbaxy, has reported consolidated sales of 23.7 billion rupees ($394 million),…

BSE SensexFinancialGenericsIndiaOver-the-counter accountingPharmaceutical industryRanbaxyRanbaxy Laboratories

Indian generic drugmakers set to score from MPP deals on HIV drugs

Indian generic drugmakers set to score from MPP deals on HIV drugs

28-07-2014

Seven new sub-licensing agreements for the manufacture of generic HIV medicines and two new generation…

Anti-viralsGenericsIndiaLicensingPatentsProduction

Glenmark reports strong growth everywhere but the USA

Glenmark reports strong growth everywhere but the USA

25-07-2014

India-based generics manufacturer Glenmark has seen its consolidated revenue increase by more than 20%…

FinancialGenericsGlenmark PharmaceuticalsIndia

Medicines Patent Pool broadens collaboration with Gilead Sciences

24-07-2014

The Medicines Patent Pool (MPP) has entered into a new licensing agreement with US biotech firm Gilead…

Anti-viralsChinaGenericsGilead SciencesIndiaLicensingProductiontenofovir alafenamide

Hospira’s Retacrit effective in chemotherapy-induced anemia

Hospira’s Retacrit effective in chemotherapy-induced anemia

24-07-2014

USA-based Hospira, a leading provider of generic injectable drugs and infusion technologies, announced…

BiosimilarsErythropoiesis-stimulating agentsGenericsHematologyHospiraInfusion technologiesResearchRetacritUSA

Hikma to take over Boehringer’s Ben Venue manufacturing site

24-07-2014

Jordan-based drugmaker Hikma Pharmaceuticals says it has agreed with Ben Venue Laboratories, part of…

Ben Venue LabsBoehringer IngelheimGenericsHikma PharmaceuticalsMergers & AcquisitionsProductionUSA

South Africa’s NAPM calls for elimination of VAT on medicines

22-07-2014

South African trade group the National Association of Pharmaceutical Manufacturers (NAPM) has proposed…

FinancialGenericsNational Association of Pharmaceutical ManufacturersPoliticsPricingSouth Africa

Mylan wins motion to enjoin GSK from providing paroxetine CR to Apotex

Mylan wins motion to enjoin GSK from providing paroxetine CR to Apotex

17-07-2014

US generics drug major Mylan says that the US District Court for the District of New Jersey granted its…

ApotexGenericsGlaxoSmithKlineLegalMylanNeurologicalparoxetinePaxil-CRUSA

Glenmark Pharma to set up new manufacturing facility in USA

Glenmark Pharma to set up new manufacturing facility in USA

17-07-2014

Indian drugmaker Glenmark Pharmaceuticals plans to set up a new manufacturing facility at Monroe Corporate…

GenericsGlenmark PharmaceuticalsProductionUSA

Pfizer to acquire generics firm InnoPharma for up to $360 million

Pfizer to acquire generics firm InnoPharma for up to $360 million

17-07-2014

Having failed (so far) in its mega billion dollar ($116 billion) attempt to buy Anglo-Swedish drug major…

GenericsInnoPharmaMergers & AcquisitionsOncologyOphthalmicsPfizer

Portugal’s pharmacists and MoH agree 60% generics market share objective

Portugal’s pharmacists and MoH agree 60% generics market share objective

16-07-2014

The Portuguese Pharmacies Association and the Ministry of Health have entered into an agreement to set…

GenericsMarkets & MarketingPortugal

Impax Labs receives subpoena over digoxin

Impax Labs receives subpoena over digoxin

16-07-2014

US generic drugmaker Impax Laboratories revealed in a Securities Exchange Commission filing that, on…

Cardio-vascularCardiologydigoxinGenericsImpax LaboratoriesLegalMarkets & MarketingUSA

Sun Pharma acquires Pharmalucence

Sun Pharma acquires Pharmalucence

16-07-2014

Sun Pharmaceutical Industries, India's third-largest generic drugmaker by sales, revealed that it has…

BSE SensexEconomy of IndiaGenericsIndiaMergers & AcquisitionsPharmalucenceProductionRanbaxy LaboratoriesSun Pharmaceuticals

FDA accepts Teva’s NDA for albuterol MDPI

FDA accepts Teva’s NDA for albuterol MDPI

15-07-2014

Israel-based generic giant Teva Pharmaceuticals Industries says that the US Food and Drug Administration…

albuterolExercise-induced bronchospasmGenericsPulmonologyRegulationRespiratory and PulmonaryTeva Pharmaceutical IndustriesUSA

60 to 84 of 1198 results

Back to top